Issue Date: Sep 30, 2010
On July 15, 1962, a Washington Post story, ‘Heroine of FDA keeps bad drug off market,’ shocked Americans. The heroine in question was Frances Oldham Kelsey. She had joined the US Food and Drug Administration two years earlier as a drug application investigator. With her expertise in pharmacology, she was the obvious choice to test the veracity of an application for a “harmless” sedative that was already being sold in 46 countries. The drug, Kevadon, was one of the trade names of thalidomide.
Recent Supreme Court order in Vedanta case holds hope for tribal community life
Butterflies on the roof of the world is a vivid and engaging narrative of the author's rendezvous with the butterflies and moths in particular, and nature in general